BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 34144270)

  • 1. A computational approach for rational discovery of inhibitors for non-structural protein 1 of SARS-CoV-2.
    Singh R; Bhardwaj VK; Das P; Purohit R
    Comput Biol Med; 2021 Aug; 135():104555. PubMed ID: 34144270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural basis for translational shutdown and immune evasion by the Nsp1 protein of SARS-CoV-2.
    Thoms M; Buschauer R; Ameismeier M; Koepke L; Denk T; Hirschenberger M; Kratzat H; Hayn M; Mackens-Kiani T; Cheng J; Straub JH; Stürzel CM; Fröhlich T; Berninghausen O; Becker T; Kirchhoff F; Sparrer KMJ; Beckmann R
    Science; 2020 Sep; 369(6508):1249-1255. PubMed ID: 32680882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling studies reveal the importance of the C-terminal inter motif loop of NSP1 as a promising target site for drug discovery and screening of potential phytochemicals to combat SARS-CoV-2.
    Prabhu D; Rajamanikandan S; Sureshan M; Jeyakanthan J; Saraboji K
    J Mol Graph Model; 2021 Jul; 106():107920. PubMed ID: 33933885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure of the SARS-CoV-2 Nsp1/5'-Untranslated Region Complex and Implications for Potential Therapeutic Targets, a Vaccine, and Virulence.
    Vankadari N; Jeyasankar NN; Lopes WJ
    J Phys Chem Lett; 2020 Nov; 11(22):9659-9668. PubMed ID: 33135884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of the binding interactions of some novel antiviral compounds against Nsp1 protein from SARS-CoV-2 (COVID-19) through high throughput screening.
    Chowdhury N; Bagchi A
    J Biomol Struct Dyn; 2022 Sep; 40(14):6634-6641. PubMed ID: 33612076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structural Basis of the Potential Binding Mechanism of Remdesivir to SARS-CoV-2 RNA-Dependent RNA Polymerase.
    Zhang L; Zhou R
    J Phys Chem B; 2020 Aug; 124(32):6955-6962. PubMed ID: 32521159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lysine 164 is critical for SARS-CoV-2 Nsp1 inhibition of host gene expression.
    Shen Z; Zhang G; Yang Y; Li M; Yang S; Peng G
    J Gen Virol; 2021 Jan; 102(1):. PubMed ID: 33151142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular Basis of SARS-CoV-2 Nsp1-Induced Immune Translational Shutdown as Revealed by All-Atom Simulations.
    Borišek J; Spinello A; Magistrato A
    J Phys Chem Lett; 2021 Dec; 12(48):11745-11750. PubMed ID: 34851631
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SARS-CoV-2 Nsp1 binds the ribosomal mRNA channel to inhibit translation.
    Schubert K; Karousis ED; Jomaa A; Scaiola A; Echeverria B; Gurzeler LA; Leibundgut M; Thiel V; Mühlemann O; Ban N
    Nat Struct Mol Biol; 2020 Oct; 27(10):959-966. PubMed ID: 32908316
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revealing druggable cryptic pockets in the Nsp1 of SARS-CoV-2 and other β-coronaviruses by simulations and crystallography.
    Borsatto A; Akkad O; Galdadas I; Ma S; Damfo S; Haider S; Kozielski F; Estarellas C; Gervasio FL
    Elife; 2022 Nov; 11():. PubMed ID: 36412088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic Analysis and Structural Perspectives of RNA-Dependent RNA-Polymerase Inhibition from SARs-CoV-2 with Natural Products.
    Khan A; Khan M; Saleem S; Babar Z; Ali A; Khan AA; Sardar Z; Hamayun F; Ali SS; Wei DQ
    Interdiscip Sci; 2020 Sep; 12(3):335-348. PubMed ID: 32617855
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug targeting Nsp1-ribosomal complex shows antiviral activity against SARS-CoV-2.
    Afsar M; Narayan R; Akhtar MN; Das D; Rahil H; Nagaraj SK; Eswarappa SM; Tripathi S; Hussain T
    Elife; 2022 Mar; 11():. PubMed ID: 35323109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The N-terminal domain of SARS-CoV-2 nsp1 plays key roles in suppression of cellular gene expression and preservation of viral gene expression.
    Mendez AS; Ly M; González-Sánchez AM; Hartenian E; Ingolia NT; Cate JH; Glaunsinger BA
    Cell Rep; 2021 Oct; 37(3):109841. PubMed ID: 34624207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Two Ligand-Binding Sites on SARS-CoV-2 Non-Structural Protein 1 Revealed by Fragment-Based X-ray Screening.
    Ma S; Damfo S; Lou J; Pinotsis N; Bowler MW; Haider S; Kozielski F
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Evolutionarily Conserved Strategy for Ribosome Binding and Host Translation Inhibition by β-coronavirus Non-structural Protein 1.
    Maurina SF; O'Sullivan JP; Sharma G; Pineda Rodriguez DC; MacFadden A; Cendali F; Henen MA; Vögeli B; Kieft JS; Glasgow A; Steckelberg AL
    J Mol Biol; 2023 Oct; 435(20):168259. PubMed ID: 37660941
    [TBL] [Abstract][Full Text] [Related]  

  • 16.
    Sharma A; Goyal S; Yadav AK; Kumar P; Gupta L
    J Biomol Struct Dyn; 2022 Jan; 40(1):86-100. PubMed ID: 32896226
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonstructural Protein 1 of SARS-CoV-2 Is a Potent Pathogenicity Factor Redirecting Host Protein Synthesis Machinery toward Viral RNA.
    Yuan S; Peng L; Park JJ; Hu Y; Devarkar SC; Dong MB; Shen Q; Wu S; Chen S; Lomakin IB; Xiong Y
    Mol Cell; 2020 Dec; 80(6):1055-1066.e6. PubMed ID: 33188728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of residues of SARS-CoV nsp1 that differentially affect inhibition of gene expression and antiviral signaling.
    Jauregui AR; Savalia D; Lowry VK; Farrell CM; Wathelet MG
    PLoS One; 2013; 8(4):e62416. PubMed ID: 23658627
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of Nonstructural Protein 1 from SARS-CoV-2.
    Clark LK; Green TJ; Petit CM
    J Virol; 2021 Jan; 95(4):. PubMed ID: 33234675
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    Wang Y; Kirkpatrick J; Zur Lage S; Korn SM; Neißner K; Schwalbe H; Schlundt A; Carlomagno T
    Biomol NMR Assign; 2021 Oct; 15(2):287-295. PubMed ID: 33770349
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.